Association of automated quantified emphysema and interstitial lung abnormality with survival in non-small cell lung cancer

The study explores artificial intelligence (AI) quantified emphysema and interstitial lung abnormality (ILA) severity in non-small cell lung cancer (NSCLC) prognosis. The AI-quantified whole emphysema severity and ILA severity were independent prognostic factors for NSCLC patient outcome, while regional emphysema and regional ILA severity were not. AI-quantified emphysema and ILA severity may help predict the survival of NSCLC patients and help clinicians make informed treatment decisions.